Physician profile
James Joye
NPI 1396751889
$95,544.72
in general payments reported to CMS, 2019-2025
17 companies · $34K in 2025
The $34K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $175 · 2021: $19K · 2022: $30K · 2023: $9,671 · 2024: $1,096 · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Travel and Lodging: $6,059 · Food and Beverage: $5,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,900.00 |
| Travel and Lodging | $6,058.82 |
| Food and Beverage | $5,283.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $49,276.23 | 2021-2022 | |
| Endologix LLC | $44,976.96 | 2022-2025 | Torus Stent Graft System, Endocross Device |
| Smith+Nephew, INC. | $225.65 | 2019 | |
| Organogenesis INC. | $182.30 | 2022-2024 | Puraply |
| Bard Peripheral Vascular, INC. | $173.30 | 2025 | Rotarexs 6 F X 135 Cm |
| Abbott Laboratories | $149.61 | 2019-2024 | Assurity |
| Bardy Diagnostics, INC. | $122.96 | 2019-2022 | |
| Boston Scientific Corporation | $110.98 | 2019-2020 | |
| Baxter Healthcare | $81.52 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Medtronic Vascular, INC. | $67.91 | 2019 | |
| Medtronic, INC. | $65.56 | 2021-2022 | |
| Amgen INC. | $28.69 | 2020 | |
| Venclose INC. | $24.38 | 2020 | |
| Cordis US Corp. | $22.89 | 2024 | Vista Brite Tip |
| W. L. Gore & Associates, INC. | $20.93 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.85 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Joye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.